Skip to main content
Tech.euFundingExplorerBeta

UI-Investissement / Pertinence Invest 2

Investor profile

Venture capital

UI-Investissement / Pertinence Invest 2 has backed 1 European tech company across 1 funding round in 2022, joining rounds totalling €31M. Most active in Healthtech. Data as of Nov 2026.

Deals
1
distinct rounds
Companies
1
backed
Active span
2022
1 yr
Total round €
€31M
sum of rounds joined

Deals by year

distinct rounds / year
UI-Investissement / Pertinence Invest 2 — deals by year — interactive chart.
Data table
UI-Investissement / Pertinence Invest 2 — deals by year
20221

Top sectors

by deals
UI-Investissement / Pertinence Invest 2 — top sectors — interactive chart.
Data table
UI-Investissement / Pertinence Invest 2 — top sectors
Healthtech1

Stages

by deals
UI-Investissement / Pertinence Invest 2 — stages — interactive chart.
Data table
UI-Investissement / Pertinence Invest 2 — stages
Series A1

Countries

by deals
UI-Investissement / Pertinence Invest 2 — countries — interactive chart.
Data table
UI-Investissement / Pertinence Invest 2 — countries
France1

Co-investment network

shared rounds
Co-investment network — interactive chart.
UI-Investissement / Pertinence Invest 2 — 1 dealsUI-Investissement / Pertinence Invest 2Crédit Agricole Création — 1 shared deals · click to openCrédit Agricole CréationElaia Partners — 1 shared deals · click to openElaia PartnersFondation Fournier-Majoie — 1 shared deals · click to openFondation Fournier-MajoieMérieux Equity Partners — 1 shared deals · click to openMérieux Equity PartnersSham Innovation Santé — 1 shared deals · click to openSham Innovation SantéSimba Santé — 1 shared deals · click to openSimba SantéSofinnova Partners — 1 shared deals · click to openSofinnova Partners

Hover a node for shared-deal counts; click a co-investor to open its profile.

Best viewed on a larger screen.

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
Mablink BioscienceFrance1€31M

Biggest deals

top 10 by amount
CompanyStageAmountDate
Mablink BioscienceSeries A€31M2022-10
← Back to investors